INIS
hiv
100%
patients
48%
botswana
46%
communities
43%
adults
42%
humans
40%
emergencies
40%
africa
40%
viruses
40%
implementation
40%
reviews
35%
levels
35%
populations
31%
screening
31%
resources
25%
hepatitis
24%
diseases
23%
schools
23%
policy
23%
children
21%
tools
21%
guidelines
21%
management
20%
learning
20%
measles
20%
evaluation
20%
control
20%
feedback
20%
kenya
20%
workers
20%
grabs
20%
monitoring
20%
data
18%
risks
13%
texas
13%
usa
11%
mortality
10%
host
10%
safety
10%
surveys
10%
attitudes
10%
education
8%
therapy
8%
morbidity
8%
assessments
7%
pathology
6%
organs
6%
central nervous system
6%
side effects
6%
disturbances
6%
Keyphrases
Pre-screening Tool
20%
Hematologic
20%
Non-progression
20%
Controller
20%
Multiple Mini-interview
20%
Gaborone
20%
Care Package
20%
Hepatitis B&C
20%
Real-world Implementation
20%
HIV Prevention Policy
20%
Policy Implementation Gap
20%
Social Innovation
20%
Lead Monitoring
20%
Measles Immunization
10%
Ocular Structures
10%
Resource-limited Settings
10%
Unique Pattern
10%
Elite Controllers
10%
Emergency Presentation
10%
Severe Infection
10%
Long-term Nonprogressors
10%
Gastrointestinal Disturbances
10%
Life-threatening Complications
10%
Disease Pathology
10%
Long-term Nonprogression
10%
Ocular Complications
10%
Psychiatric Complications
10%
Residency Match
8%
Upper Level
6%
Introductory Course
6%
Family Model
5%
Clinical Case Management
5%
Measles Outbreak
5%
Specific Settings
5%
Domestic Violence Screening
5%
Associated Comorbidities
5%
Comprehensive Health
5%
HIV Treatment Program
5%
Tuberculosis Breast
5%
Injury Prevention
5%
Tuberculosis Prevention
5%
Methods Guidance
5%
Regional Literature
5%
Public Sector
5%
Resource Areas
5%
Prevention Guidelines
5%
External Injury
5%
Local Environment
5%
Medicine and Dentistry
Human Immunodeficiency Virus
60%
Human Immunodeficiency Virus Infection
42%
Emergency
40%
Therapeutic Procedure
40%
Prevalence
27%
Human Immunodeficiency Virus 1 Infection
20%
Hepatitis B
20%
Adult
20%
Hepatitis C
20%
Mixed Infection
20%
Life
16%
Patient
15%
Disease
12%
Complication
12%
Diagnosis
10%
Antiretroviral Therapy
10%
Pathology
8%
Heart Disease
8%
Infection
8%
Immune System
8%
Mortality
8%
Gastrointestinal Distress
8%
Side Effect
8%
Organ Systems
8%
Central Nervous System
8%
Hepatitis B Antigen
7%
Long-Term Nonprogressor
6%
Family
5%
Screening
5%
